Canada News Beep | NewsBeep.com
  • News Beep
  • Canada
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology
Canada News Beep | NewsBeep.com
Canada News Beep | NewsBeep.com
  • News Beep
  • Canada
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology

Browsing Tag

category: General

11 posts
BBusiness
BlackBerry's Quiet Comeback: The Software Powering 275 Million Cars Turns Heads (CORRECTED) - BlackBerry
Read More

BlackBerry’s Quiet Comeback: The Software Powering 275 Million Cars Turns Heads (CORRECTED) – BlackBerry

  • May 4, 2026
Editor’s Note: This article has been updated to correct the name of QNX’s president. BlackBerry Ltd. (NYSE:BB) no…
HHealthcare
What's Going On With Novo Nordisk Stock Thursday? - Novo Nordisk (NYSE:NVO)
Read More

What’s Going On With Novo Nordisk Stock Thursday? – Novo Nordisk (NYSE:NVO)

  • April 27, 2026
Oral Semaglutide Shows Superior Glycaemic Control The phase 3a study evaluated oral semaglutide in patients aged 10–17 years…
HHealthcare
Novo Nordisk Extends Lead As Eli Lilly New Obesity Pill Sees Modest Launch Uptake - Eli Lilly (NYSE:LLY)
Read More

Novo Nordisk Extends Lead As Eli Lilly New Obesity Pill Sees Modest Launch Uptake – Eli Lilly (NYSE:LLY)

  • April 18, 2026
Early Prescription Trends Show Slower Start For Lilly Reuters, citing IQVIA data, reported that Eli Lilly recorded 1,390…
SSpace
Oklo CEO Says Nuclear Powers Everything 'That's Cool In Space' - Oklo (NYSE:OKLO)
Read More

Oklo CEO Says Nuclear Powers Everything ‘That’s Cool In Space’ – Oklo (NYSE:OKLO)

  • April 17, 2026
Everything Cool Needs Nuclear When asked if goals for nuclear-powered space exploration were far-fetched, DeWitte argued nuclear power…
MMedication
Novo Nordisk Sued Over Alleged Scheme To Delay Generic Victoza In Favor Of Ozempic - Novo Nordisk (NYSE:NVO)
Read More

Novo Nordisk Sued Over Alleged Scheme To Delay Generic Victoza In Favor Of Ozempic – Novo Nordisk (NYSE:NVO)

  • January 31, 2026
Novo Nordisk A/S (NYSE:NVO) is accused of unlawfully extending its monopoly over its diabetes drug Victoza through a…
SSoccer
Soccer Coach Beats Nike To 'Total 90' Trademark, Sparks Legal Fight Ahead Of World Cup - Nike (NYSE:NKE)
Read More

Soccer Coach Beats Nike To ‘Total 90’ Trademark, Sparks Legal Fight Ahead Of World Cup – Nike (NYSE:NKE)

  • December 26, 2025
Nike Inc. (NYSE:NKE) is facing a trademark lawsuit that could complicate its marketing strategy ahead of the upcoming…
HHealthcare
Novo Nordisk's $100 Million Coramitug Shows Promise In Reducing Heart Failure Biomarker - Novo Nordisk (NYSE:NVO)
Read More

Novo Nordisk’s $100 Million Coramitug Shows Promise In Reducing Heart Failure Biomarker – Novo Nordisk (NYSE:NVO)

  • November 12, 2025
In a presentation at the American Heart Association’s (AHA’s) 2025 Scientific Sessions, researchers on Tuesday shared data from…
HHealthcare
What's Going On With Novo Nordisk Stock Monday? - Novo Nordisk (NYSE:NVO)
Read More

What’s Going On With Novo Nordisk Stock Monday? – Novo Nordisk (NYSE:NVO)

  • August 25, 2025
The U.S. Food and Drug Administration (FDA) has identified repeated quality control failures, including foreign particle contamination, inadequate…
HHealthcare
UnitedHealth Vs. Novo Nordisk: Which Healthcare Giant Fits Your Portfolio? - Novo Nordisk (NYSE:NVO), UnitedHealth Group (NYSE:UNH)
Read More

UnitedHealth Vs. Novo Nordisk: Which Healthcare Giant Fits Your Portfolio? – Novo Nordisk (NYSE:NVO), UnitedHealth Group (NYSE:UNH)

  • August 20, 2025
Two healthcare giants, UnitedHealth Group Inc UNH and Novo Nordisk A/S NVO, are duking it out in very…
BBusiness
Why Is UnitedHealth Stock Trading Higher Friday? - UnitedHealth Group (NYSE:UNH)
Read More

Why Is UnitedHealth Stock Trading Higher Friday? – UnitedHealth Group (NYSE:UNH)

  • August 15, 2025
UnitedHealth Group Inc. UNH shares climbed Friday after high-profile investors Michael Burry and Warren Buffett took positions in…
HHealthcare
Eli Lilly's Orforglipron Data Is Not Disastrous: Analyst - Eli Lilly (NYSE:LLY)
Read More

Eli Lilly’s Orforglipron Data Is Not Disastrous: Analyst – Eli Lilly (NYSE:LLY)

  • August 12, 2025
Eli Lilly and Co LLY released underwhelming data from a Phase 3 ATTAIN-1 trial evaluating orforglipron, an investigational…
Canada News Beep | NewsBeep.com
www.newsbeep.com